On May 10, 2021, the Food and Drug Administration issued updated age restrictions for the Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine. HHSC modified the vaccine on the Medicaid and Children’s Health Insurance Program (CHIP) formularies to be a payable pharmacy benefit for individuals 12 years and older, effective May 10, 2021. HHSC will continue to follow the Medicare rate for vaccine administration.
|Pfizer-BioNTech||COVID-19 Vaccine EUA||59267-1000-01|
|Pfizer-BioNTech||COVID-19 Vaccine EUA||59267-1000-02|